Evidence map›Paper›PMID 38188296›Full record

ArticleFrontiers in oncology2023

Multi-parametric MRI-based radiomics for preoperative prediction of multiple biological characteristics in endometrial cancer.

Changjun Ma, Ying Zhao, Qingling Song, Xing Meng, Qihao Xu, Shifeng Tian, Lihua Chen, Nan Wang, Qingwei Song, Liangjie Lin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Changjun Ma *Department of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Ying Zhao *Department of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Qingling SongDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Xing MengDalian Women and Children's Medical Group, Dalian, China.
Qihao XuDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Shifeng TianDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Lihua ChenDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Nan WangDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Qingwei SongDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Liangjie LinClinical & Technical Support, Philips Healthcare, Beijing, China.
Jiazheng WangClinical & Technical Support, Philips Healthcare, Beijing, China.
Ailian LiuDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Artificial Intelligence in Medicine (Canada) · CAFirst Affiliated Hospital of Dalian Medical University · CNDalian Medical University · CNPhilips (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To develop and validate multi-parametric MRI (MP-MRI)-based radiomics models for the prediction of biological characteristics in endometrial cancer (EC). Methods: A total of 292 patients with EC were divided into LVSI ( Results: In the training cohort, the RF radiomics model performed best among the five classifiers for the three subsets (MSI, LVSI, and DMI) according to AUC values (AUC Conclusion: The radiomics analysis based on MP-MRI and clinical independent risk factors can potentially predict multiple biological features of EC, including DMI, LVSI, MSI, and Her-2, and provide valuable guidance for clinical decision-making.

Indexed as

deep myometrium invasionendometrial cancerhuman epidermal growth factor receptor-2lympho-vascular space invasionmicrosatellite instabilityradiomics

Identifiers

PMID38188296
PMCPMC10768555
OpenAlexW4389785885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.